ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

SAVA Cassava Sciences Inc

22.095
-0.245 (-1.10%)
최종 업데이트: 23:35:17
15분 지연
기업명 주식 심볼 시장 주식 타입
Cassava Sciences Inc SAVA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.245 -1.10% 22.095 23:35:17
개장가 저가 고가 종가 전일 종가
22.33 22.00 22.50 22.34
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
15/04/202422:20GLOBERedemption Date Announced for Warrants
25/03/202422:13GLOBECassava Sciences Announces Completion of an Interim Safety..
04/03/202423:15GLOBECassava Sciences Announces Virtual Presentation at the..
29/02/202406:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/02/202423:22EDGAR2Form 8-K - Current report
28/02/202423:14GLOBECassava Sciences Reports Full-year 2023 Financial Results..
07/02/202423:20EDGAR2Form 8-K - Current report
07/02/202423:08GLOBENo Decline in Cognition Scores in Patients with Mild..
02/02/202406:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/01/202406:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/01/202423:12GLOBECassava Sciences Completes Dividend Distribution of Warrants..
04/01/202406:24EDGAR2Form CERT - Certification by an exchange approving..
04/01/202406:22EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
04/01/202406:18EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
03/01/202423:10EDGAR2Form 8-K - Current report
02/01/202423:10EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
12/12/202323:19EDGAR2Form 8-K - Current report
12/12/202323:13GLOBECassava Sciences Announces Dividend Distribution of Warrants..
12/12/202306:18EDGAR2Form 8-K - Current report
09/12/202307:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202306:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202306:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202306:01GLOBECassava Sciences Appoints Three New Members to its Board of..
07/11/202323:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202323:08EDGAR2Form 8-K - Current report
07/11/202323:01GLOBECassava Sciences Reports Third Quarter 2023 Financial and..
06/11/202323:15GLOBECassava Sciences Completes Enrollment for Pivotal Phase 3..
25/10/202322:15GLOBEMRI Data Suggest Simufilam is Not Associated with..
13/10/202322:06IHMARKETNEWSFriday’s Wall Street Highlights: Dollar General, Microsoft,..
13/10/202312:43GLOBEStatement by Cassava Sciences Regarding an Internal CUNY..
05/10/202322:15GLOBECassava Sciences to Present at the Jefferies Biotech..
05/10/202307:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202307:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202307:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202307:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:00GLOBECassava Sciences Completes Patient Enrollment for Pivotal..
18/09/202322:15GLOBECassava Sciences Announces Positive Interim Safety Review of..
14/09/202305:17EDGAR2Form 8-K - Current report
11/09/202322:10GLOBECassava Sciences Announces Science Publication That Confirms..
06/09/202322:15GLOBECassava Sciences Invited to Present in Four Upcoming..
25/08/202305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202305:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202305:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/08/202322:12EDGAR2Form 8-K - Current report
03/08/202322:07GLOBECassava Sciences Reports Q2 2023 Financial Results and..
05/07/202322:25EDGAR2Form 8-K - Current report
05/07/202322:15GLOBEOral Simufilam Slowed Cognitive Decline in a Randomized..
27/06/202322:15GLOBENew Research Shows Simufilam Suppresses Overactive mTOR
12/06/202322:15GLOBENew Publication Highlights Basic Science Supporting..
01/06/202322:15GLOBECassava Sciences to Present at the Jefferies Global..

최근 히스토리

Delayed Upgrade Clock